Topics › Life Sciences › Immunology and Microbiology › Immunology
Biosimilars and Bioanalytical Methods Sign in to save
Papers per year
Papers 36
Open in paper search →-
P326 Reasons for and effectiveness of switching back to originator infliximab after a prior switch to CT-P13 biosimilar2020 Journal of Crohn s and Colitis conference-abstract Immunology and Microbiology Biosimilars and Bioanalytical Methods
Shaden Mahmmod, Johannes P. D. Schultheiss, Adriaan C.I.T.L. Tan, Maurice W. M. D. Lutgens, Lennard P. L. Gilissen, Nofel Mahmmod, +5 more
3citations -
Effectiveness of biosimilar infliximab CT-P13 compared to originator infliximab in biological-naïve patients with rheumatoid arthritis and axial spondyloarthritis: data from the Portuguese Register.
José Marona, Alexandre Rocha Sepriano, Sofía Ramiro, Diogo Esperança Almeida, Luísa Brites, Maura Couto, +11 more
1citations -
Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience2025 British Journal of Clinical Pharmacology article Immunology and Microbiology Biosimilars and Bioanalytical Methods Open access
Juliette A. van den Noort, Marella C. E. van Ruissen, Lisanne C.A. Smidt, Naomi B. Klarenbeek, Philip H. C. Kremer, Manon A. A. Jansen, +3 more
1citations -
Author’s Response to Letter to the Editor - Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613–6272022 Current Medical Research and Opinion letter Immunology and Microbiology Biosimilars and Bioanalytical Methods Open access
Yinong Young‐Xu, Richard Melsheimer, Bruno Émond, Patrick Lefèbvre, Maral DerSarkissian, Angela Lax, +4 more
0citations -
POS0567 COMPARISON OF SURVIVAL ON TREATMENT AMONG NEW USERS OF BIOSIMILAR VS. ORIGINATOR BIOLOGICS IN INFLAMMATORY ARTHRITIS: POPULATION-BASED EVIDENCE FROM A NATURAL EXPERIMENT DUE TO A POLICY CHANGE2023 Annals of the Rheumatic Diseases conference-abstract Immunology and Microbiology Biosimilars and Bioanalytical Methods Open access
D. Lacaille, Juan Antonio Aviña-Zubieta, Yan Zheng, Na Lu, Hui Wen Xie
0citations -
Clinical Validation of Venetoclax Volumetric Microsampling in Patients with Leukemia with Assessment of Whole-Blood-to-Plasma Conversion Strategies and Self-Microsampling Feasibility2026 Clinical Pharmacokinetics article Immunology and Microbiology Biosimilars and Bioanalytical Methods Open access
Amar D. Levens, J. Rijstenbil, E. Metscher, P. A. von dem Borne, A. Albersen, J.J. Swen, +1 more
0citations -
How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis2026 Clinical Pharmacokinetics review Immunology and Microbiology Biosimilars and Bioanalytical Methods Open access
Cassandra Weng-Yan Lai, Suzanne A.M. Wenker, Paul W. Groundwater, Justin Beardsley, Gaurav Sutrave, Ricky Hao Chen, +2 more
0citations
Most active Aachen authors
-
Piet H. van der Graaf 6,134 citations overall4 papers
-
Dirk Jan A. R. Moes 4,889 citations overall4 papers
-
Richard Melsheimer 470 citations overall4 papers
-
Jeroen N. Stoop 3,111 citations overall3 papers
-
Tom W. J. Huizinga 99,423 citations overall2 papers
-
Andrea E. van der Meulen‐de Jong 9,618 citations overall2 papers
-
Juan Antonio Aviña-Zubieta 8,941 citations overall2 papers
-
Hui Wen Xie 4,851 citations overall2 papers
-
D. Lacaille 310 citations overall2 papers
-
Manfred Wuhrer 32,864 citations overall1 paper
-
Wim Jiskoot 29,701 citations overall1 paper
-
Thomas Hankemeier 29,177 citations overall1 paper
-
Sofía Ramiro 18,788 citations overall1 paper
-
Arjan C. Lankester 16,396 citations overall1 paper
-
Jesse Joachim Swen 13,791 citations overall1 paper